Drug company gives ofatumumab update
Drug company gives ofatumumab update
Biotech firm Genmab has announced an update on development plans for ofatumumab in autoimmune indications focusing on relapsing multiple sclerosis following the transfer of the rights to ofatumumab from GlaxoSmithKline (GSK) to Novartis at the end of 2015...Read more - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1300 Views
-
Last post by frodo
-
- 0 Replies
- 963 Views
-
Last post by frodo
-
- 0 Replies
- 2300 Views
-
Last post by NHE
-
- 0 Replies
- 1269 Views
-
Last post by frodo
-
- 0 Replies
- 1225 Views
-
Last post by frodo
-
- 0 Replies
- 1183 Views
-
Last post by frodo
-
- 0 Replies
- 1442 Views
-
Last post by NHE
-
- 0 Replies
- 468 Views
-
Last post by NHE
-
- 1 Replies
- 2908 Views
-
Last post by Tif